Snyder Mark Howard 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Snyder Mark Howard
SVP, CHIEF LEGAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2026-01-03+7,611→ 38,424 total - Tax Payment
Common Stock
2026-01-03$70.31/sh−4,243$298,325→ 34,181 total - Exercise/Conversion
Restricted Stock Units
2026-01-03−7,611→ 0 totalExercise: $0.00→ Common Stock (7,611 underlying)
Footnotes (2)
- [F1]The reported disposition of 4,243 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- [F2]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.